Bio Green Med Solution, Inc.
BGMS· Nasdaq
Released May 14, 2026, after the close
10-Q filed May 15, 2026, 45 days after period end · 0001493152-26-023800
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $743.00K | — | $29.00K | $0.00 |
| Net Income | -$197.00K | -$81.00K | -$2.95M | -$5.80M |
| EPS Diluted |
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR
| -$0.04 |
| $0.00 |
| -$2.27 |
| -$7.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.